regn1979 for patients with previously treated cd20 positive b-cell malignancies
Published 8 years ago • 1.4K plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
6:11
redlamp 9: prognostic factors for clinical outcomes in patients with plasmablastic lymphoma
-
4:19
lymphoma program | weill cornell medicine
-
2:29
ibrutinib plus palbociclib clinical trial | lymphoma | weill cornell medical college | new york
-
2:08
lymphoma cancer research ny | clinical trials | b-cell lymphoma | weill cornell lymphoma
-
2:18
azacitidine plus r-chop clinical trial for lymphoma | weill cornell | lymphoma program
-
1:58
non-hodgkin lymphoma treatment ny | blood cancer | cancer center | weill cornell lymphoma
-
8:09
redlamp 13: how are outcomes improving for patients with transformed follicular lymphoma?
-
7:27
rajat bannerji: regn1979 active across non-hodgkin lymphoma subtypes
-
3:15
weill cornell mantle cell lymphoma (mcl) program
-
2:50
weill cornell mantle cell lymphoma (mcl) research
-
1:00
dr. roth on treating aya patients with hodgkin lymphoma
-
6:44
updates on reg1979 in r/r b-cell non-hodgkins lymphoma
-
4:15
redlamp 1: low serum vitamin d levels are associated with inferior survival in follicular lymphoma
-
2:19
chronic lymphocytic lymphoma treatment ny | clinical trials | cll | weill cornell lymphoma
-
21:17
new anti-cd20 antibodies for cll - are they better than rituximab?
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
22:46
follicular lymphoma debate: chemotherapy no longer has a major role in the treatment
-
2:24
nivolumab for relapsed hodgkin lymphoma clinical trial | weill cornell medical college | new york